Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer

Immunotherapy has become a very effective treatment for many cancers. It has a unique set of immune system-related adverse effects, collectively known as immune-related adverse events (irAEs). Skin toxicities are the most common irAEs, of which bullous pemphigoid, although rare, is potentially life-...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Ting Wang, Qianwen Shao, Chunmei Xiao, Lianke Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Subjects:	bullous pemphigoid PD-1 fruquintinib sintilimab pMMR/MSS mCRC
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1124730/full